Used in pharmaceutical research as an intermediate for synthesizing bioactive compounds targeting metabolic and neurological disorders. Shows potential in the development of enzyme inhibitors due to its structural affinity for specific receptor sites. Its morpholine and thiazole moieties enhance solubility and binding efficiency, making it suitable for optimizing drug candidates in preclinical studies. Also employed in structure-activity relationship (SAR) studies to improve pharmacokinetic properties of therapeutic agents.